To investigate the protective efficacy and immunomodulatory potential of single dose combination of SSG along with KLD / 78 kDa antigen + MPL-in inbred BALB / c mice

Visceral Leishmaniasis (VL) is a disease of poor and neglected populations; it affects 79 countries of the world and accounts 58,000 new cases to each year. However, no effective treatment for cure of the disease is yet available. Therefore, the present study was designed to assess the curative efficacy of single dose of sodium stibogluconate in combination… CONTINUE READING